AAOI
Applied Optoelectronics, Inc.
AAOI offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
ACN
Accenture plc
ACN has the edge over AAOI overall, supported by lower modeled downside and stronger valuation.
AAOI Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
AAOI's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
ACN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
ACN's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
AAOI PE Valuation
AAOI has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 18x next year's earnings.
ACN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 17x | $250 | — |
| Current | 18x | $250 | — |
| Cheap | 21x | $285 | +14% |
| Fair | 28x | $381 | +52% |
| Expensive | 33x | $447 | +79% |
Historical ranges are pointers, not guarantees.
ACN's PE is in its cheap range at 18x. If earnings grow as analysts expect, today's price would be 17x next year's earnings.
AAOI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
AAOI has the edge over ACN on the outlook, with more favorable profitability expectations.
ACN Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Stable | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for ACN, with profitability holding steady.
AAOI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.98 | — |
| Q3 2026 | -$0.42 | +$3.02 |
| Q2 2026 | -$0.77 | +$2.81 |
| Q1 2026 | -$0.65 | +$3.43 |
| Q4 2025 | -$0.64 | +$3.86 |
| Q3 2025 | -$3.44 | -$1.41 |
| Q2 2025 | -$3.58 | -$1.70 |
| Q1 2025 | -$4.08 | -$2.29 |
| Q4 2024 | -$4.50 | -$2.75 |
AAOI is still losing money, but far less than before: $0.42 per share over the past year, against $4.50 at its worst in late 2024.
ACN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $14.67 | +8.2% |
| Q3 2026 | $13.56 | +12% |
| Q2 2026 | $12.52 | -0.3% |
| Q1 2026 | $12.21 | +0.8% |
| Q4 2025 | $12.10 | +1.5% |
| Q3 2025 | $12.15 | +6.3% |
| Q2 2025 | $12.56 | +15% |
| Q1 2025 | $12.11 | +9.8% |
| Q4 2024 | $11.92 | +10% |
ACN has the edge over AAOI on earnings quality, reporting a profit while its opponent remains loss making.
AAOI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $269.9M | +127% |
| Q2 2026 | $191.9M | +86% |
| Q1 2026 | $151.1M | +51% |
| Q4 2025 | $134.3M | +34% |
| Q3 2025 | $118.6M | +82% |
| Q2 2025 | $103M | +138% |
| Q1 2025 | $99.9M | +146% |
| Q4 2024 | $100.3M | +66% |
AAOI has the edge over ACN on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -0.5% | +15 points |
| Q2 2026 | -13% | +2.6 points |
| Q1 2026 | -8.6% | +0.3 points |
| Q4 2025 | -8.6% | -2.1 points |
| Q3 2025 | -15% | +10 points |
| Q2 2025 | -16% | +45 points |
| Q1 2025 | -8.9% | +44 points |
| Q4 2024 | -6.5% | +1 points |
AAOI's operating margin was −0.5% last quarter, up 15 points from the same quarter a year ago, near the top of its range since 2019.
ACN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $18.7B | +6.2% |
| Q2 2026 | $18.7B | +5.6% |
| Q1 2026 | $18B | +8.3% |
| Q4 2025 | $18.7B | +6% |
| Q3 2025 | $17.6B | +7.3% |
| Q2 2025 | $17.7B | +7.7% |
| Q1 2025 | $16.7B | +5.4% |
| Q4 2024 | $17.7B | +9% |
ACN's revenue has grown year over year for nine quarters in a row: $18.7B last quarter, up 6.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +3.7 points |
| Q2 2026 | 17% | +0.1 points |
| Q1 2026 | 14% | +0.3 points |
| Q4 2025 | 15% | -1.3 points |
| Q3 2025 | 12% | -2.7 points |
| Q2 2025 | 17% | +0.8 points |
| Q1 2025 | 13% | +0.5 points |
| Q4 2024 | 17% | +0.9 points |
ACN has the edge over AAOI on profitability, with a higher operating margin.
AAOI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$369.9M | -$291.2M |
| Q2 2026 | -$265.3M | -$174.4M |
| Q1 2026 | -$143.6M | -$64.3M |
| Q4 2025 | -$104.6M | -$51.6M |
| Q3 2025 | -$78.7M | -$58M |
| Q2 2025 | -$91M | -$86M |
| Q1 2025 | -$79.3M | -$45.1M |
| Q4 2024 | -$53M | -$48.4M |
AAOI has burned cash in almost every quarter: −$883M over the past year, against −$302M the year before.
ACN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.8B | -25% |
| Q2 2026 | $3.6B | +2.4% |
| Q1 2026 | $3.7B | +37% |
| Q4 2025 | $1.5B | +73% |
| Q3 2025 | $3.8B | +20% |
| Q2 2025 | $3.5B | +16% |
| Q1 2025 | $2.7B | +35% |
| Q4 2024 | $870.3M | +103% |
ACN has the edge over AAOI on cash generation, producing positive trailing cash flow while its opponent burns cash.
AAOI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +7.7% | +6.3M shares |
| 1 year | +39% | +24.5M shares |
| 3 years | +168% | +55.1M shares |
| 5 years | +224% | +60.7M shares |
| Available history | +340% | +67.9M shares |
AAOI has 88M diluted shares, up 39% from a year ago.
ACN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.7% | -10.3M shares |
| 1 year | -3.8% | -24.1M shares |
| 3 years | -5.3% | -34M shares |
| 5 years | -6.2% | -40M shares |
| Available history | -6.8% | -44.1M shares |
ACN has the edge over AAOI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $2.3B |
| Q2 2026 | $1.2B |
| Q1 2026 | $1.7B |
| Q4 2025 | $2.3B |
| Q3 2025 | $473.9M |
| Q2 2025 | $1.8B |
| Q1 2025 | $1.4B |
| Q4 2024 | $898.3M |
ACN spent $7.5B buying back its own shares over the past year, up 63% from the year before.
AAOI Net Leverage
AAOI's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ACN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.4x | Net Cash |
| Q4 2025 | -0.4x | Net Cash |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | -0.3x | Net Cash |
ACN has more cash than debt.
AAOI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.1 | Neutral |
| Stochastic | 4.8 | Oversold |
AAOI's weekly RSI is 35 (neutral) and its Stochastic is 5 (oversold).
ACN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 67.6 | Neutral |
| Stochastic | 88.9 | Overbought |
ACN's weekly RSI is 68 (neutral) and its Stochastic is 89 (overbought).
AAOI PE vs Technology Sector
AAOI has no meaningful PE right now: it lost money over the past year.
ACN PE vs Technology Sector
| Metric | ACN | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 28x | 34% below |
| PE % | 10 | 35 | 25 pts below |
ACN is trading at 18x earnings, a 34% discount to the Technology sector's median of 28x.
AAOI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $80.2 | 34% below |
| 20 week MA | $100.6 | 47% below |
| 50 week MA | $100.3 | 47% below |
| 100 week MA | $62.3 | 15% below |
| 200 week MA | $36.9 | 43% above |
AAOI has fallen below most of its moving averages, though it's still 43% above its 200-week average.
ACN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $229.0 | 9.2% above |
| 20 week MA | $192.0 | 30% above |
| 50 week MA | $204.9 | 22% above |
| 100 week MA | $250.4 | 0.2% below |
| 200 week MA | $285.4 | 12% below |
ACN has the edge over AAOI on trend strength, trading above more of its moving averages.
AAOI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $11.5 | $8.77 | -24% |
| 2021 | $8.77 | $5.64 | -36% |
| 2022 | $5.64 | $1.95 | -65% |
| 2023 | $1.95 | $19.3 | +891% |
| 2024 | $19.3 | $37.7 | +95% |
| 2025 | $37.7 | $37.2 | -1.5% |
| 2026 YTD | $37.2 | $52.9 | +42% |
AAOI has the edge over ACN on returns for 2026, with the stronger performance.
ACN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $212.2 | $257.3 | +21% |
| 2021 | $257.3 | $403.3 | +57% |
| 2022 | $403.3 | $266.1 | -34% |
| 2023 | $266.1 | $350.9 | +32% |
| 2024 | $350.9 | $356.2 | +1.5% |
| 2025 | $356.2 | $271.1 | -24% |
| 2026 YTD | $271.1 | $250.0 | -7.8% |
ACN has finished higher in four of the last six years. It's down 7.8% so far in 2026.